Cargando…

Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et al

Detalles Bibliográficos
Autores principales:	Brunner, Hermine, Graham Lomax, Kathleen, Levy, Stephane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437052/ https://www.ncbi.nlm.nih.gov/pubmed/25512026 http://dx.doi.org/10.1002/art.38992

Ejemplares similares

Evidence inconclusive - comment on article by Schoenfeld et al
por: Beale, David J.
Publicado: (2016)

Brief Comment on the Article about Human Anaplasmosis by Arraga-Alvarado et al.
por: de Tamí, Irene Maury, et al.
Publicado: (2015)

Comments to Article by Thoene M et al., Nutrients 2016, 8, 451
por: Moya, Fernando
Publicado: (2016)

Comments to Article by Willetts A. et al., Microorganisms 2016, 4, 38
por: Littlechild, Jennifer A., et al.
Publicado: (2017)

Comments to Article by Solah VA et al., Nutrients 2017, 9, 149
por: Vuksan, Vladimir, et al.
Publicado: (2017)

Obesity paradox in sarcopenia and knee osteoarthritis: comment on the article by Andrews et al
por: Mezian, Kamal, et al.
Publicado: (2021)

Fibromyalgia criteria and anomalous results: comment on the article by Ghavidel‐Parsa et al
por: Wolfe, Frederick, et al.
Publicado: (2022)

Comment on the Article by Torun et al. Entitled ‘Serum Paraoxonase 1 Activity and Oxidative Stress in Pediatric Patients with Pulmonary Tuberculosis’
por: Agilli, Mehmet, et al.
Publicado: (2015)

STEMI time delays: a clinical perspective: Editorial comment on the article by Verweij et al.
por: de Boer, M-J., et al.
Publicado: (2015)

Vaccination rates, perceptions, and information sources in inflammatory arthritis: Comment on the article by Lyon et al
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Off-label use of canakinumab in pediatric rheumatology and rare diseases
por: Del Giudice, Emanuela, et al.
Publicado: (2022)

Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020)

Comment on the Article: Choroidal Thickness in Pediatric Populations
por: Prousali, Efthymia, et al.
Publicado: (2021)

Retraction of articles by T. Liu et al.
por: Liu, T., et al.
Publicado: (2009)

Response to Dr. Moya’s Comments to Article by Thoene M et al., Nutrients 2016, 8, 451
por: Thoene, Melissa, et al.
Publicado: (2016)

Influence of HLA-B27 Subtypes on Ankylosing Spondylitis Phenotype: Comment on the Article by Akassou et al
por: Fallahi, Sasan
Publicado: (2018)

Comment on Brocklehurst et al.
por: Paul, Gregory
Publicado: (2019)

Retraction of articles by H. Zhong et al.
por: Zhong, H., et al.
Publicado: (2009)

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
por: Horneff, G, et al.
Publicado: (2015)

Response to Comments by Vuksan V. et al., Nutrients 2017, 9, 398, Regarding an Article by Solah V.A. et al., Nutrients 2017, 9, 149
por: Solah, Vicky A., et al.
Publicado: (2017)

Reply to Comment by Young et al.
por: Mathews, F., et al.
Publicado: (2009)

Response to comment by Moxon et al.
por: Thompson, Dawn, et al.
Publicado: (2018)

Response to comment by Guerra et al.
por: Yang, Xinyue, et al.
Publicado: (2018)

Reply to the comment by Osuka et al.
por: Endo, Akira, et al.
Publicado: (2020)

Response to Collinson et al. Comment
por: Belmonte, Miriam, et al.
Publicado: (2020)

Comment on Karriker-Jaffe et al.
por: Karjalainen, Karoliina
Publicado: (2018)

Comment to the Article “Prevention of B Thalassemia in Northern Israel - A Cost-Benefit Analysis” by Koren et al.1
por: Amato, Antonio
Publicado: (2014)

Antineutrophil cytoplasmic antibody, glomerulonephritis and inactivated SARS‐CoV‐2 vaccine: comment on the article by Garcia et al
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on Murphy et al.: Pediatric orthopaedic lower extremity trauma and venous thromboembolism
por: Marangoz, Salih
Publicado: (2016)

Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
por: Gül, Ahmet, et al.
Publicado: (2015)

Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States
por: Hur, Peter, et al.
Publicado: (2021)

OR10-006 - Canakinumab in patients with TRAPS
por: Lachmann, HJ, et al.
Publicado: (2013)

Canakinumab and Lung Cancer: Intriguing, but Is It Real?
por: Chabner, Bruce A., et al.
Publicado: (2018)

Treatment of refractory Yao syndrome with canakinumab
por: Brailsford, Caroline J., et al.
Publicado: (2022)

A Letter to the Editor on the Article by Farnam et al
por: Rutte, Anne, et al.
Publicado: (2015)

Statistical issues regarding the article by Liu et al.
por: Marques-Vidal, Pedro
Publicado: (2020)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Electroconvulsive Therapy and Oxidative Stress: Comment on the Article of Şenyurt et al. (Clin Psychophacol Neurosci 2017;15:40–46)
por: Kalelioglu, Tevfik, et al.
Publicado: (2017)

Comment on a paper by Maley et al.
por: Metcalf, M
Publicado: (1996)

Response to comment from Brasky et al.
por: Verdoodt, F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kvsdt3ijun1uuv8ri2bidrbtr1